We have reported that aldehyde dehydrogenase activity (termed ALDH+) and CD44+CD24− mark two largely non-overlapping populations of cancer stem cells, which have epithelial-like and mesenchymal-like phenotypes, respectively (Liu et al., 2013). The gene discussed is CD44; the disease is cancer.